Elsevier Announces the Launch of a New Journal: Trends in Environmental Analytical Chemistry (TrEAC) - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Elsevier Announces the Launch of a New Journal: Trends in Environmental Analytical Chemistry (TrEAC)


Elsevier Announces the Launch of a New Journal: Trends in Environmental Analytical Chemistry (TrEAC)

PR Newswire

AMSTERDAM, February 20, 2014 /PRNewswire/ --

First issue of Trends in Environmental Analytical Chemistry now available online on ScienceDirect

Elsevier, a world-leading provider of scientific, technical and medical information products and solutions, is pleased to announce the launch today of a new journal: Trends in Environmental Analytical Chemistry (TrEAC).

Published as a quarterly journal and adding to Elsevier's Analytical Chemistry portfolio of journals, Trends in Environmental Analytical Chemistry will publish concise and critical overviews of the rapid changes and development in the field of environmental analytical chemistry.

"Continuous advancements in novel measurement techniques and analytical protocols are making analysis and detection of many new or previously unrecognized contaminants possible, resulting in a higher awareness of the environmental problems we are facing today," said Editor-in-Chief, Dr. Mira Petrovic, ICRA-Catalan Institute for Water Research, Girona, Spain.

Dr. Paul Carton, Publishing Director Chemistry at Elsevier, added, "The acquisition, sound interpretation and dissemination of high quality chemical data in environmental systems, the three-fold mission of this new journal, is the essential basis for enhancing our understanding of the environment at a time of challenge when it has never been more important that we do so."

All articles published in the first issue are available on ScienceDirect: http://www.sciencedirect.com/science/journal/22141588

For more information about the journal or to submit an article, go to: http://www.journals.elsevier.com/trends-in-environmental-analytical-chemistry

# # #

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell , and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Darren Sugrue
Elsevier
+31-20-485-3506
d.sugrue@elsevier.com

SOURCE Elsevier

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
88%
Borrow lightly from EMA's pathway program?
4%
Create entirely its own pathway program?
8%
View Results
Untitled Document

Click here